FNA Tumor Sampling for CD137 Modulation: A Pilot Study
Trial ID or NCT#
NCT01114256
Status
NOT RECRUITING
Purpose
The purpose of this study is to better understand the biology of the body's immune response to monoclonal antibody therapy for cancer. Your health information will be used to identify your tissues. The tissue we obtain may be useful for ÌÇÐÄ´«Ã½ or education, resulting in new drugs, therapies or diagnostic procedures.
Official Title
FNA Tumor Sampling for CD137 Modulation: A Pilot Study
Eligibility Criteria
Ages Eligible for Study: Older than 21 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Exclusion Criteria:
Investigator(s)
A. Dimitrios Colevas, MD
Medical oncologist,
Head and neck specialist,
Cutaneous oncology specialist
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Contact us to find out if this trial is right for you.
Contact
Risa Jiron
650-736-1598
View on